Fujisawa, Japan

Shunro Mori

This inventor holds 1 USPTO granted patent. Top assignee: Sanraku-Ocean Co., Ltd.. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shunro Mori. Retrieved from https://idiyas.com/inventor/shunro-mori-ehcputco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shunro Mori: Innovator in Tylosin Derivatives

Introduction

Shunro Mori is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on tylosin derivatives. His innovative approach has led to advancements that enhance the efficacy of existing compounds.

Latest Patents

Mori holds 1 patent for his work on tylosin derivatives. His patent focuses on a number of 4'-acyl derivatives of tylosin and acetyltylosin. These derivatives are prepared by a multi-step process that involves protective acylation at specific hydroxyl groups. The resulting compounds demonstrate a higher blood level compared to previously known tylosin derivatives, showcasing their potential for improved therapeutic applications.

Career Highlights

Throughout his career, Mori has been associated with Sanraku-ocean Co., Ltd. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the development of new pharmaceutical solutions. His dedication to research and innovation has been instrumental in advancing the field.

Collaborations

Mori has collaborated with notable colleagues such as Rokuro Okamoto and Taiji Inui. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Shunro Mori's contributions to the field of tylosin derivatives exemplify the impact of innovative thinking in pharmaceuticals. His work continues to influence the development of new therapeutic options, underscoring the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…